Difference between revisions of "Part:BBa K3034000"
(→Expression of CrpP-Histag) |
|||
| Line 2: | Line 2: | ||
<partinfo>BBa_K3034000 short</partinfo> | <partinfo>BBa_K3034000 short</partinfo> | ||
| − | CrpP is a novel ciprofloxacin-modifying enzyme which can phosphorylate | + | CrpP is a novel ciprofloxacin(CIP)-modifying enzyme which can phosphorylate CIP. Then the phosphorylated CIP goes through multiple steps of degradation spontaneously and produces 1,4-dihydroquinoline finally[1]. 1,4-dihydroquinoline is used as a kind of new carriers for specific brain delivery [2], so we can infer that it's nontoxic. This part is responsible for degradation of ciprofloxacin in our project. |
<!-- Add more about the biology of this part here | <!-- Add more about the biology of this part here | ||
| Line 14: | Line 14: | ||
===Molecular weight=== | ===Molecular weight=== | ||
| − | This gene codes for a protein of 65 amino acids with a molecular mass about | + | This gene codes for a protein of 65 amino acids with a molecular mass about 11 kDa.When with a 6×Histag, the weight reaches about 15kDa. |
===Expression of CrpP-Histag=== | ===Expression of CrpP-Histag=== | ||
| − | + | Because expression of CrpP-Histag is unsatisfying in E.coli ''DH5α'', so we clone pelB-5D, CrpP with 6×Histag and TagRFP CDS into an expression vector, then the vector is transformed into E.coli ''BL21(DE3)''. 0.5mM IPTG is used for protein's expression and (over)expression is monitered by 17% SDS-PAGE. | |
| − | [[File: SDS-PAGE of CrpP-Histag.png|500px|thumb|center|'''Fig. 1''' SDS-PAGE of CrpP-Histag. M: Protein ladder; Lane 2、3: | + | [[File: SDS-PAGE of CrpP-Histag.png|500px|thumb|center|'''Fig. 1''' SDS-PAGE of CrpP-Histag. M: Protein ladder; Lane 2、3: Experimental group 1 (0.5mM IPTG is added); Lane 3、4: Control group 1 (without 0.5mM IPTG); Lane 5、6: Experimental group 2; Lane 7、8: Control group 2. The protein between 25kDa and 33kDa is TagRFP]] |
===Enzyme activity of CrpP=== | ===Enzyme activity of CrpP=== | ||
Revision as of 01:08, 12 October 2019
CrpP：Ciprofloxacin-Modifying Enzyme
CrpP is a novel ciprofloxacin(CIP)-modifying enzyme which can phosphorylate CIP. Then the phosphorylated CIP goes through multiple steps of degradation spontaneously and produces 1,4-dihydroquinoline finally[1]. 1,4-dihydroquinoline is used as a kind of new carriers for specific brain delivery [2], so we can infer that it's nontoxic. This part is responsible for degradation of ciprofloxacin in our project.
Sequence and Features
- 10COMPATIBLE WITH RFC[10]
- 12COMPATIBLE WITH RFC[12]
- 21COMPATIBLE WITH RFC[21]
- 23COMPATIBLE WITH RFC[23]
- 25COMPATIBLE WITH RFC[25]
- 1000COMPATIBLE WITH RFC[1000]
Contents
Characterization
Molecular weight
This gene codes for a protein of 65 amino acids with a molecular mass about 11 kDa.When with a 6×Histag, the weight reaches about 15kDa.
Expression of CrpP-Histag
Because expression of CrpP-Histag is unsatisfying in E.coli DH5α, so we clone pelB-5D, CrpP with 6×Histag and TagRFP CDS into an expression vector, then the vector is transformed into E.coli BL21(DE3). 0.5mM IPTG is used for protein's expression and (over)expression is monitered by 17% SDS-PAGE.
Enzyme activity of CrpP
References
[1]Chávez-Jacobo, Víctor M., et al. CrpP is a novel ciprofloxacin-modifying enzyme encoded by the Pseudomonas aeruginosa pUM505 plasmid. Antimicrobial agents and chemotherapy 62.6 (2018): e02629-17.
[2]Foucout, et al. Synthesis, radiosynthesis and biological evaluation of 1, 4-dihydroquinoline derivatives as new carriers for specific brain delivery. Organic & biomolecular chemistry 7.18 (2009): 3666-3673.